Immunogenicity 11362
Sample ID
3775
Response
Negative
Tumor Type
Cervical Carcinoma(HPV+)
Gene Symbol
PNN
Transcript ID
uc001wuw.4
HLA INFO
B*35:01
TCR INFO
No TCR info found!
Full length protein sequence (717 aa)
MAVAV
1
RTLQE
6
QLEKA
11
KESLK
16
NVDEN
21
IRKLT
26
GRDPN
31
DVRPI
36
QARLL
41
ALSGP
46
GGGRG
51
RGSLL
56
LRRGF
61
SDSGG
66
GPPAK
71
QRDLE
76
GAVSR
81
LGGER
86
RTRRE
91
SRQES
96
DPEDD
101
DVKKP
106
ALQSS
111
VVATS
116
KERTR
121
RDLIQ
126
DQNMD
131
EKGKQ
136
RNRRI
141
FGLLM
146
GTLQK
151
FKQES
156
TVATE
161
RQKRR
166
QEIEQ
171
KLEVQ
176
AEEER
181
KQVEN
186
ERREL
191
FEERR
196
AKQTE
201
LRLLE
206
QKVEL
211
AQLQE
216
EWNEH
221
NAKII
226
KYIRT
231
KTKPH
236
LFYIP
241
GRMCP
246
ATQKL
251
IEESQ
256
RKMNA
261
LFEGR
266
RIEFA
271
EQINK
276
MEARP
281
RRQSM
286
KEKEH
291
QVVRN
296
EEQKA
301
EQEEG
306
KVAQR
311
EEELE
316
ETGNQ
321
HNDVE
326
IEEAG
331
EEEEK
336
EIAIV
341
HSDAE
346
KEQEE
351
EEQKQ
356
EMEVK
361
MEEET
366
EVRES
371
EKQQD
376
SQPEE
381
VMDVL
386
EMVEN
391
VKHVI
396
ADQEV
401
METNR
406
VESVE
411
PSENE
416
ASKEL
421
EPEME
426
FEIEP
431
DKECK
436
SLSPG
441
KENVS
446
ALDME
451
KESEE
456
KEEKE
461
SEPQP
466
EPVAQ
471
PQPQS
476
QPQLQ
481
LQSQS
486
QPVLQ
491
SQPPS
496
QPEDL
501
SLAVL
506
QPTPQ
511
VTQEQ
516
GHLLP
521
ERKDF
526
PVESV
531
KLTEV
536
PVEPV
541
LTVHP
546
ESKSK
551
TKTRS
556
RSRGR
561
ARNKT
566
SKSRS
571
RSSSS
576
SSSSS
581
SSTSS
586
SSGSS
591
SSSGS
596
SSSRS
601
SSSSS
606
SSTSG
611
SSSRD
616
SSSST
621
SSSSE
626
SRSRS
631
RGRGH
636
NRDRK
641
HRRSV
646
DRKRR
651
DTSGL
656
ERSHK
661
SSKGG
666
SSRDT
671
KGSKD
676
KNSRS
681
DRKRS
686
ISESS
691
RSGKR
696
SSRSE
701
RDRKS
706
DRKDK
711
RR
716
Mutation Information
DNA mutation:
None
Peptide Range:
435 ~ 459
Mut AA position:
447 (13 in Wild Type peptide)
Alignment
Wild Type:
"PDKECKSLSPGKENVSALDMEKESE
||||||||||||.||||||||||||
Mutant:
PDKECKSLSPGKKNVSALDMEKESE"
Science, 2017
Landscape of immunogenic tumor antigens in successful immunotherapy of virally induced epithelial cancerGene Name (from Reference) PNN
Checkpoint
Blockade
None
ACT
None
Vaccination
None
Curative
Effect
None
minimal_peptide
None
Antigen
Type
TMG RNA
T-cell
Source
TILs
APC
Type
autologous DCs
Assay
IFNg ELISPOT assay